A study to find key factors affecting recovery in ARDS patients
Part of Lungs & breathing clinical trials.
This study looks at blood and sputum samples from people with ARDS (a severe lung condition) to find what affects their recovery. It might help doctors better understand how to treat ARDS in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have ARDS, a serious lung condition with low oxygen levels.
- You must be medically stable for at least 12 to 24 hours before joining.
- You must not have major long-term lung disease or a weakened immune system.
- You must be able to provide blood and sputum samples and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study looks at how a specific pathway (called RSPO3/SDC-1) helps repair damaged lungs in older adults with ARDS. It may help doctors find new ways to improve recovery after severe breathing problems.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
Hear when a new Microbiome Dysbiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.